top of page
{84E89673-CE3E-4FA7-BDDE-461B1CFEBC28}.png

Patient Scholarship Opportunity to attend CCRC 2025, Nov 2-4 in Calgary, Alberta

This is a unique opportunity for cholangiocarcinoma patients to raise the profile of this rare cancer within Canada’s research community, connect with other patients and caregivers from across the country, learn about emerging science and treatment approaches, and help shape the national conversation on cancer research and care.

 

Scholarship Details:

We currently have funding for 4 full patient scholarships (covering travel up to $400, accommodations up to $800, and the $300 conference registration fee). Applications beyond this number will be placed on a waitlist. If additional funds remain after awarding the full scholarships, we will make every effort to extend support to waitlisted applicants which may include covering registration fees or providing partial scholarships. All scholarship recipients will given a short post-conference survey to capture the main take-aways of the conference.

Please note that being on the waitlist does not guarantee financial support.

All reimbursements will be made after the conference upon submission of receipts.

 

Application Details:

  • Scholarships will only be awarded to patients living with cholangiocarcinoma

  • To be considered for a scholarship, you must complete this form by October 1, 2025

  • Applications will be reviewed independently by members of the C3 Steering Committee, with identifying details removed during the review process.

  • All applicants will be notified of the outcome by October 7, 2025.

  • Scholarship recipients should plan to arrive in Calgary by November 1, as the Canadian Cancer Research Conference begins early the morning of November 2.

 

For questions or more information please contact: events@cholangio.ca 

  • Instagram
  • Facebook
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

The Canadian Cholangiocarcinoma Collaborative (C3) is supported by a Canadian Cancer Society Breakthrough Team Grant in partnership with the Canadian Institutes of Health Research. The granting funds for C3 are managed by The Ottawa Hospital Research Institute, which serves as the lead institute for all collaborative operations.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page